StonvexLoading…
StonvexStonvexStonvexCore line items from HCC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.31B | $1.53B | $1.68B | $1.74B |
Operating Income | $45.71M | $254.89M | $541.41M | $801.42M |
Net Income | $57.00M | $250.60M | $478.63M | $641.30M |
EPS (Diluted) | $1.08 | $4.79 | $9.20 | $12.40 |
Total Assets | $2.78B | $2.59B | $2.36B | $2.03B |
Total Liabilities | $642.41M | $500.70M | $482.61M | $580.58M |
Cash & Equivalents | $299.96M | $491.55M | $738.20M | $829.48M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $636.66M |
Shares Outstanding | 52.57M | 52.31M | 52.02M | 51.65M |